Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Globus Medical Inc 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 USA

P: 610-930-1800

Description:

Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 5,093,740
Shares Outstanding, K 99,100
Annual Sales, $ 712,970 K
Annual Net Income, $ 156,470 K
Last Quarter Sales, $ 194,540 K
Last Quarter Net Income, $ 38,160 K
60-Month Beta 0.97
% of Insider Shareholders 24.97%
% of Institutional Shareholders 67.90%
Float, K 74,355
% Float 75.03%

Growth:

1-Year Return -2.17%
3-Year Return 122.61%
5-Year Return 149.15%
5-Year Revenue Growth 64.10%
5-Year Earnings Growth 85.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.41 on 08/01/19
Next Earnings Date 11/06/19
Earnings Per Share ttm 1.59
EPS Growth vs. Prev Qtr 13.89%
EPS Growth vs. Prev Year -6.82%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

GMED Ratios

Ratio
Price/Earnings ttm 32.08
Price/Earnings forward N/A
Price/Earnings to Growth 2.65
Return-on-Equity (After Tax) 1.48
Return-on-Assets (Before Tax) 1.05
Profit Margin % 21.95
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 7.09
Price/Cash Flow 23.64
Price/Book 3.93
Book Value/Share 12.99
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar